Fu plans to further explore the link between PLK1 and MAPK signaling in prostate cancer patients and determine whether PLK1 - induced EMT contributes to other cancer - promoting processes that go beyond cell migration and metastasis.
It actively engages biologists working on distinct molecular mechanisms of cellsmigration and helps them interact beyond the boundaries of independent laboratories.